JBCHEPHARM.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:00):

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally...

Stats
Tagesvolumen	72 656.00
Durchschnittsvolumen	190 885
Marktkapitalisierung	289.45B
EPS	INR0 ( 2024-02-07 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-21
Last Dividend	INR9.25 ( 2023-08-16 )
Next Dividend	INR0 ( N/A )
P/E	57.14
ATR14	INR3.56 (0.19%)

Volumen Korrelation

Lang: 0.02 (neutral)

Kurz: -0.81 (strong negative)

Signal:(52.375) Neutral

J. B. Chemicals & Korrelation

10 Am meisten positiv korreliert
ASIANHOTNR.NS	0.803

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

J. B. Chemicals & Korrelation - Währung/Rohstoff

0.08
( neutral )

-0.06
( neutral )

-0.34
( neutral )

0.17
( neutral )

-0.12
( neutral )

0.23
( neutral )

J. B. Chemicals & Finanzdaten

Annual	2022
Umsatz:	INR31.49B
Bruttogewinn:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Umsatz:	INR31.49B
Bruttogewinn:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Umsatz:	INR24.24B
Bruttogewinn:	INR15.61B (64.39 %)
EPS:	INR49.86

FY	2021
Umsatz:	INR20.06B
Bruttogewinn:	INR12.88B (64.23 %)
EPS:	INR57.96

Financial Reports:

No articles found.

J. B. Chemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR8.00 (N/A)	INR0 (N/A)	INR8.50 (N/A)	INR0 (N/A)	INR9.25 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

J. B. Chemicals & Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.86 - low (61.49%) | Divividend Growth Potential Score: 5.35 - Stable (7.08%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.600	2003-06-30
Last Dividend	INR9.25	2023-08-16
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR149.65	--
Avg. Dividend % Per Year	1.66%	--
Score	3.52	--
Div. Sustainability Score	4.86
Div.Growth Potential Score	5.35
Div. Directional Score	5.11	--

Next Divdend (Est)
(2024-12-10)

INR9.67 Estimate 6.79 %

Dividend Stability

0.27 Very Poor

Dividend Score

3.52

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.00	0.62%
2019	INR5.00	3.21%
2020	INR12.00	5.59%
2021	INR16.50	3.19%
2022	INR16.50	1.89%
2023	INR17.75	1.80%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SANDHAR.NS	Dividend Junior	2023-09-14	Annually	7	0.66%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GLENMARK.NS	Dividend Junior	2023-09-18	Annually	23	0.37%
ASIANPAINT.NS	Dividend Junior	2023-06-09	Semi-Annually	23	0.43%
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%
SHYAMMETL.NS	Dividend Junior	2023-06-05	Semi-Annually	4	0.70%
MAXHEALTH.NS	Dividend Junior	2023-09-08	Insufficient data to determine frequency	2	0.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.198	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	59.22	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	14.16	2.00	2.92	5.84	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.890	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.855	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	56.25	1.000	4.42	0	[1 - 100]
returnOnEquityTTM	0.198	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	14.16	2.00	5.28	5.84	[0 - 30]
dividendYielPercentageTTM	0.543	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	8.93	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0648	1.000	-0.879	0	[0.1 - 0.5]
Total Score				5.35

J. B. Chemicals &

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.